Catalog
Unintentional exposure to or harmful effects of agents primarily affecting blood constituents
No MMS code
Link to WHO Definition
Unintentional exposure to or harmful effects of agents primarily affecting blood constituents – http://id.who.int/icd/entity/908049813
Parents
Children
- Unintentional exposure to or harmful effects of enzymes
- Unintentional exposure to or harmful effects of natural blood or blood products
- Unintentional exposure to or harmful effects of antineoplastic natural products
- Unintentional exposure to or harmful effects of diphenhydramine
- Unintentional exposure to or harmful effects of anticoagulants
- Unintentional exposure to or harmful effects of antiallergic or antiemetic drugs
- Unintentional exposure to or harmful effects of immunosuppressive agents
- Unintentional exposure to or harmful effects of other primarily systemic agents, not elsewhere classified
- Unintentional exposure to or harmful effects of acidifying or alkalising agents
- Unintentional exposure to or harmful effects of anticoagulant antagonists, vitamin K or other coagulants
- Unintentional exposure to or harmful effects of other fibrinolysis-affecting drugs
- Unintentional exposure to or harmful effects of antineoplastic antimetabolites
- Unintentional exposure to or harmful effects of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations
- Unintentional exposure to or harmful effects of other H1-receptor antagonists
- Unintentional exposure to or harmful effects of other antineoplastic drugs
- Unintentional exposure to or harmful effects of plasma substitutes
- Unintentional exposure to or harmful effects of antithrombotic drugs
- Unintentional exposure to or harmful effects of iron or its compounds
- Unintentional exposure to or harmful effects of thrombolytic drug